WAM
LJPC

Wolverine Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Wolverine Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,338
Closed -$1.12M – 1751
2017
Q3 		$1.12M Buy
+32,338
New +$1.04M 0.01% 622

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Asset Management's LJPC Position: Q4 2017 in Review

Wolverine Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2017, closing a stake of 32,338 shares — an estimated $1.12M sold.

Wolverine Asset Management first reported a position in LJPC in Q3 2017 and held it in 1 quarter. The position peaked at $1.12M in Q3 2017. 93 funds tracked by Wall St. Rank hold LJPC as of Q4 2017.

  • Wolverine Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2017 after selling out during the quarter.
  • Wolverine Asset Management sold 32,338 La Jolla Pharmaceutical Company shares in Q4 2017, an estimated $1.12M.
  • Wolverine Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 1 quarter.
  • Wolverine Asset Management's La Jolla Pharmaceutical Company position peaked at $1.12M in Q3 2017.
  • 93 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2017.

Based on Wolverine Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.